← Back to Search
Design, Synthesis, And Structure-activity Relationships Of Alkylcarbamic Acid Aryl Esters, A New Class Of Fatty Acid Amide Hydrolase Inhibitors.
G. Tarzia, A. Duranti, A. Tontini, G. Piersanti, M. Mor, S. Rivara, P. Plazzi, Chris Park, S. Kathuria, D. Piomelli
Published 2003 · Chemistry, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Fatty acid amide hydrolase (FAAH), an intracellular serine hydrolase enzyme, participates in the deactivation of fatty acid ethanolamides such as the endogenous cannabinoid anandamide, the intestinal satiety factor oleoylethanolamide, and the peripheral analgesic and anti-inflammatory factor palmitoylethanolamide. In the present study, we report on the design, synthesis, and structure-activity relationships (SAR) of a novel class of potent, selective, and systemically active inhibitors of FAAH activity, which we have recently shown to exert potent anxiolytic-like effects in rats. These compounds are characterized by a carbamic template substituted with alkyl or aryl groups at their O- and N-termini. Most compounds inhibit FAAH, but not several other serine hydrolases, with potencies that depend on the size and shape of the substituents. Initial SAR investigations suggested that the requirements for optimal potency are a lipophilic N-alkyl substituent (such as n-butyl or cyclohexyl) and a bent O-aryl substituent. Furthermore, the carbamic group is essential for activity. A 3D-QSAR analysis on the alkylcarbamic acid aryl esters showed that the size and shape of the O-aryl moiety are correlated with FAAH inhibitory potency. A CoMSIA model was constructed, indicating that whereas the steric occupation of an area corresponding to the meta position of an O-phenyl ring improves potency, a region of low steric tolerance on the enzyme active site exists corresponding to the para position of the same ring. The bent shape of the O-aryl moieties that best fit the enzyme surface closely resembles the folded conformations observed in the complexes of unsaturated fatty acids with different proteins. URB524 (N-cyclohexylcarbamic acid biphenyl-3-yl ester, 9g) is the most potent compound of the series (IC(50) = 63 nM) and was therefore selected for further optimization.
This paper references
Modulation of anxiety through blockade of anandamide hydrolysis
S. Kathuria (2003)
The Protein Data Bank
H. Berman (2000)
α‐Keto Heterocycle Inhibitors of Fatty Acid Amide Hydrolase: Carbonyl Group Modification and α‐Substitution.
D. Boger (2001)
Novel inhibitors of brain, neuronal, and basophilic anandamide amidohydrolase.
L. De Petrocellis (1997)
357. Studies in qualitative organic analysis. identification of alkyl halides, amines, and acids
E. L. Brown (1937)
948. Carcinogenic nitrogen compounds. Part XIII. Benzacridines, benzocarbazoles, and related compounds bearing ethyl and propyl groups
N. P. Buu‐Hoï (1952)
Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase.
D. Deutsch (1997)
Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids.
I. Petitpas (2001)
The N-acylation-phosphodiesterase pathway and cell signalling.
H. H. Schmid (1996)
The endocannabinoid system as a target for therapeutic drugs.
D. Piomelli (2000)
Crossvalidation, Bootstrapping, and Partial Least Squares Compared with Multiple Regression in Conventional QSAR Studies
R. Cramer (1988)
Structural Adaptations in a Membrane Enzyme That Terminates Endocannabinoid Signaling
M. Bracey (2002)
Isolation and structure of a brain constituent that binds to the cannabinoid receptor.
W. Devane (1992)
Evidence that methyl arachidonyl fluorophosphonate is an irreversible cannabinoid receptor antagonist
S. Fernando (1997)
Lipophilic Sulfophenylcarbocyanine Dyes: Synthesis of a New Class of Fluorescent Cell Membrane Probes.
W. Leung (1996)
The fatty acid amide hydrolase (FAAH).
D. Deutsch (2002)
The fatty acid amide hydrolase (FAAH).
N. Ueda (2000)
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
V. Marzo (1994)
The Collinearity Problem in Linear Regression. The Partial Least Squares (PLS) Approach to Generalized Inverses
S. Wold (1984)
Exploration of biologically relevant conformations of anandamide, 2-arachidonylglycerol, and their analogues using conformational memories.
J. Barnett-Norris (1998)
Brain monoglyceride lipase participating in endocannabinoid inactivation
T. V. Dinh (2002)
Clarifying the Catalytic Roles of Conserved Residues in the Amidase Signature Family*
M. Patricelli (2000)
Inhibition of Oleamide Hydrolase Catalyzed Hydrolysis of the Endogenous Sleep-Inducing Lipid cis-9-Octadecenamide
J. Patterson (1996)
Functional role of high-affinity anandamide transport, as revealed by selective inhibition.
M. Beltramo (1997)
Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor.
D. Deutsch (1997)
Some Analogs of Synthetic Tetrahydrocannabinol
G. Alles (1942)
Comparative Molecular Similarity Index Analysis (CoMSIA) to study hydrogen-bonding properties and to score combinatorial libraries
G. Klebe (1999)
Stereochemistry of the σ-Complex Intermediate in Sterically Hindered Electrophilic Aromatic Substitutions. (20th communication on diazo coupling reactions)†
F. Snyckers (1970)
Control of pain initiation by endogenous cannabinoids
A. Calignano (1998)
Structural insights into the stereochemistry of the cyclooxygenase reaction
J. Kiefer (2000)
An endogenous sleep-inducing compound is a novel competitive inhibitor of fatty acid amide hydrolase.
M. Patricelli (1998)
Synthesis and characterization of diazomethylarachidonyl ketone: an irreversible inhibitor of N-arachidonylethanolamine amidohydrolase.
W. Edgemond (1998)
Identification of active sites in amidase: evolutionary relationship between amide bond- and peptide bond-cleaving enzymes.
M. Kobayashi (1997)
Chemical and mutagenic investigations of fatty acid amide hydrolase: evidence for a family of serine hydrolases with distinct catalytic properties.
M. Patricelli (1999)
Trifluoromethyl ketone inhibitors of fatty acid amide hydrolase: a probe of structural and conformational features contributing to inhibition.
D. Boger (1999)
Fatty acid amide hydrolase: biochemistry, pharmacology, and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide, and oleamide.
C. Fowler (2001)
An anorexic lipid mediator regulated by feeding
F. D. Fonseca (2001)
Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.
G. Klebe (1994)
Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide.
D. Boger (2000)
REACTIONS WITH 1-CHLOROCARBONYLBENZOTRIAZOLE, II. SYNTHESIS OF CARBAMATES AND RELATED COMPOUNDS
I. Butula (1978)
Naphthylamidinourea and Its Reactions with Amines
T. Urbański (1959)
740. Polymerisation of flavans. Part I. The condensation of methoxybenzyl alcohols with phenols
B. Brown (1957)
Inhibitors of arachidonoyl ethanolamide hydrolysis.
B. Koutek (1994)
The palmitoylethanolamide family: a new class of anti-inflammatory agents?
D. Lambert (2002)
Adipocyte lipid-binding protein complexed with arachidonic acid. Titration calorimetry and X-ray crystallographic studies.
J. LaLonde (1994)
See the following for a review
H. H. Schmid (1996)
Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase.
P. Reggio (2000)
The productive conformation of arachidonic acid bound to prostaglandin synthase.
M. Malkowski (2000)
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
B. Cravatt (1996)
Crystal structure and thermodynamic analysis of human brain fatty acid-binding protein.
G. Balendiran (2000)
Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94
T. Halgren (1996)
Studies in qualitative organic analysis
W. J. Levy (1939)
Structural determinants for recognition and translocation by the anandamide transporter.
D. Piomelli (1999)
Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications.
T. Bisogno (2002)
This paper is referenced by
Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models
O. Sasso (2013)
Structure-activity relationships of alpha-ketooxazole inhibitors of fatty acid amide hydrolase.
Christophe Hardouin (2007)
Optimization of alpha-ketooxazole inhibitors of fatty acid amide hydrolase.
F. Kimball (2008)
Organic Carbamates in Drug Design and Medicinal Chemistry
A. Ghosh (2015)
Inhibitors of the endocannabinoid-degrading enzymes, or how to increase endocannabinoid's activity by preventing their hydrolysis.
Marion Feledziak (2012)
Continuous-Flow Synthesis of meta-Substituted Phenol Derivatives
J. H. Park (2015)
3‐Heterocycle‐Phenyl N‐Alkylcarbamates as FAAH Inhibitors: Design, Synthesis and 3D‐QSAR Studies
Heikki Käsnänen (2010)
Carbamoylimidazolium and thiocarbamoylimidazolium salts: novel reagents for the synthesis of ureas, thioureas, carbamates, thiocarbamates and amides
J. A. Grzyb (2005)
Geometrical Isomerism and Stability of Mono- and Dichalcogenide Analogs of Carbamic Acid H2NC(=X)YH (X, Y = O, S, Se)
Damanjit Kaur (2006)
Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: modulation at the N-portion of biphenyl-3-yl alkylcarbamates.
M. Mor (2008)
Novel natural and synthetic ligands of the endocannabinoid system.
L. Hanuš (2010)
Correlation between energetics of collisionally activated decompositions, interaction energy and biological potency of carbamate FAAH inhibitors.
Giovanni Valitutti (2007)
Screening of Various Hormone‐Sensitive Lipase Inhibitors as Endocannabinoid‐Hydrolyzing Enzyme Inhibitors
Anna Minkkilae (2009)
Brain molecules and appetite: the case of oleoylethanolamide.
Andrea Sarro-Ramírez (2013)
Covalent inhibitors of fatty acid amide hydrolase: a rationale for the activity of piperidine and piperazine aryl ureas.
G. Palermo (2011)
The collisional behavior of ESI-generated protonated molecules of some carbamate FAAH inhibitors isosteres and its relationships with biological activity.
Giovanni Valitutti (2009)
The importance of hydrogen bonding and aromatic stacking to the affinity and efficacy of cannabinoid receptor CB2 antagonist, 5-(4-chloro-3-methylphenyl)-1-[(4-methylphenyl)methyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]hept-2-yl]-1H-pyrazole-3-carboxamide (SR144528).
Evangelia Kotsikorou (2013)
Docking based virtual screening and molecular dynamics study to identify potential monoacylglycerol lipase inhibitors.
O. Afzal (2014)
SYNTHESIS OF THIADIAZOLE BASED CARBAMATES AS POTENT ENDOCANNABINOID-HYDROLYZING ENZYME INHIBITORS
Yahaya Adams (2013)
The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
S. Gaetani (2009)
Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract.
M. Salaga (2014)
A perspective review on fatty acid amide hydrolase (FAAH) inhibitors as potential therapeutic agents.
R. K. P. Tripathi (2019)
Aryl and heteroaryl N-[4-[4-(2,3-substituted-phenyl)piperazine-1-yl]alkyl]carbamates with improved physico-chemical properties as dual modulators of dopamine D3 receptor and fatty acid amide hydrolase
A. Micoli (2016)
Pretreatment with the monoacylglycerol lipase inhibitor URB602 protects from the long-term consequences of neonatal hypoxic–ischemic brain injury in rats
S. Carloni (2012)
CAY10499, a Novel Monoglyceride Lipase Inhibitor Evidenced by an Expeditious MGL Assay
G. Muccioli (2008)
The Endocannabinoid Signaling System in the CNS: A Primer.
C. Hillard (2015)
Fatty Acid Amide Hydrolase: From Characterization to Therapeutics
G. Labar (2007)
Endocannabinoid system and mood disorders: priming a target for new therapies.
V. Micale (2013)
The endocannabinoid system: physiology and pharmacology.
F. Rodríguez de Fonseca (2005)
Biosynthesis, total synthesis, structural modifications, bioactivity, and mechanism of action of the quinone‐methide triterpenoid celastrol
Y. Lu (2020)
Cellular viability effects of fatty acid amide hydrolase inhibition on cerebellar neurons
K. Lüneberg (2011)
Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids
E. Puighermanal (2012)See more